Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
You can save money and still enjoy life. Discover creative ways to balance your lifestyle with your financial goals.
27,563 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
ServiceNow stock falling today captures a moment of fear about AI disruption and rising expectations. This article br...
A CAPO oracle misconfiguration on Aave led to $27 million in liquidations and a torrent of bot activity. Aave promise...
Blend Labs reports a profitable fourth quarter as a rebound in mortgage activity boosts revenue and renews optimism f...
As advertisers shift to privacy-first strategies, Viant Technology (DSP) 2025 presents both opportunities and risks. ...
Rocket Lab reports record backlog and margin gains, while Intuitive Machines pursues a transformative acquisition to ...
IREN is reshaping its business from crypto mining to AI data centers. This analysis dives into how the move affects i...
U.S. drone output is under scrutiny as manufacturers push for scale. Red Cat and AeroVironment highlight a market shi...
A trio of overlooked U.S. value stocks combines strong balance sheets with cheap earnings multiples, making them cand...
A major fund sold a sizable stake in Darling Ingredients, but the stock defied expectations and surged. This article ...
Considering your first rental property means weighing local comfort against the pull of ambitious markets. This guide...
As Berkshire Hathaway transitions from Buffett to Greg Abel, Abel makes a bold opening move. This piece explains the ...